Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boxer

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenograftsJason L J Dearling, Aiden A Flynn, Julie Sutcliffe-Goulden, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Synergy between vascular targeting agents and antibody-directed therapyR Barbara Pedley, Ethaar El-Emir, Aiden A Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapyElena F Fidarova, Ethaar El-Emir, Geoffrey M Boxer, et al.
Cancer Research|December 20, 2007
Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomasEthaar El Emir, Uzma Qureshi, Jason L J Dearling, et al.
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
Molecular Cancer Research : MCR|October 29, 2005
CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50Ido Paz-Priel, Dong Hong Cai, Dehua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapySurinder K Sharma, R Barbara Pedley, Jeetendra Bhatia, et al.
Nucleic Acids Research|January 1, 1997
Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 geneG Collod-Béroud, C Béroud, L Adès, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibodyA Mayer, E Tsiompanou, D O'Malley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrugAstrid Mayer, Roslyn J Francis, Surinder K Sharma, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenograftsJason L J Dearling, Aiden A Flynn, Julie Sutcliffe-Goulden, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Synergy between vascular targeting agents and antibody-directed therapyR Barbara Pedley, Ethaar El-Emir, Aiden A Flynn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapyElena F Fidarova, Ethaar El-Emir, Geoffrey M Boxer, et al.
Cancer Research|December 20, 2007
Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomasEthaar El Emir, Uzma Qureshi, Jason L J Dearling, et al.
Physics in Medicine and Biology|November 16, 2002
Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimatesI A Petrie, A A Flynn, R B Pedley, et al.
Molecular Cancer Research : MCR|October 29, 2005
CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50Ido Paz-Priel, Dong Hong Cai, Dehua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapySurinder K Sharma, R Barbara Pedley, Jeetendra Bhatia, et al.
Nucleic Acids Research|January 1, 1997
Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 geneG Collod-Béroud, C Béroud, L Adès, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibodyA Mayer, E Tsiompanou, D O'Malley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrugAstrid Mayer, Roslyn J Francis, Surinder K Sharma, et al.
Pageof 19